Biocon (NSE:BIOCON) Has Affirmed Its Dividend Of ₹0.50
May 12
Have your own idea? Try our Stock Screener
Indian (NIFTY) Biotech Industry Analysis
UpdatedMay 29, 2025
DataAggregated Company Financials
Companies9
- 7D-1.0%
- 3M10.8%
- 1Y9.1%
- YTDn/a
Over the last 7 days, the Biotech industry has remained flat, although notably Panacea Biotec gained 7.4%. As for the the longer term, the industry is up 11% over the past 12 months. As for the next few years, earnings are expected to grow by 20% per annum.
Industry Valuation and Performance
Has the Indian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 29 May 2025 | ₹456.1b | ₹163.8b | ₹10.6b | 56.4x | 43.1x | 2.8x |
| Sat, 26 Apr 2025 | ₹428.5b | ₹158.8b | ₹8.5b | 53.1x | 50.2x | 2.7x |
| Mon, 24 Mar 2025 | ₹457.2b | ₹158.9b | ₹8.4b | 51.2x | 54.7x | 2.9x |
| Wed, 19 Feb 2025 | ₹444.2b | ₹158.9b | ₹8.4b | 50.3x | 53.2x | 2.8x |
| Fri, 17 Jan 2025 | ₹523.0b | ₹159.6b | ₹14.5b | 58.4x | 36x | 3.3x |
| Sun, 15 Dec 2024 | ₹480.3b | ₹159.6b | ₹14.5b | 39.3x | 33x | 3x |
| Tue, 12 Nov 2024 | ₹470.3b | ₹159.0b | ₹14.3b | 39.7x | 32.8x | 3x |
| Thu, 10 Oct 2024 | ₹462.8b | ₹157.7b | ₹15.7b | 31.2x | 29.4x | 2.9x |
| Sat, 07 Sep 2024 | ₹492.3b | ₹157.7b | ₹15.7b | 34.5x | 31.3x | 3.1x |
| Mon, 05 Aug 2024 | ₹469.4b | ₹157.3b | ₹10.4b | 41.7x | 45.3x | 3x |
| Wed, 03 Jul 2024 | ₹462.7b | ₹157.4b | ₹10.4b | 44x | 44.7x | 2.9x |
| Fri, 31 May 2024 | ₹401.4b | ₹157.3b | ₹10.3b | 44.8x | 39x | 2.6x |
| Sun, 28 Apr 2024 | ₹396.7b | ₹155.4b | ₹12.0b | 37.5x | 33x | 2.6x |
| Tue, 26 Mar 2024 | ₹328.2b | ₹155.4b | ₹12.0b | 33.1x | 27.3x | 2.1x |
| Thu, 22 Feb 2024 | ₹357.5b | ₹155.4b | ₹12.0b | 42.3x | 29.7x | 2.3x |
| Sat, 20 Jan 2024 | ₹361.8b | ₹145.0b | ₹5.3b | 58.7x | 68.8x | 2.5x |
| Mon, 18 Dec 2023 | ₹331.2b | ₹145.0b | ₹5.3b | 54.4x | 63x | 2.3x |
| Wed, 15 Nov 2023 | ₹301.7b | ₹145.0b | ₹5.2b | 53.2x | 57.6x | 2.1x |
| Fri, 13 Oct 2023 | ₹341.8b | ₹133.8b | ₹4.8b | 32.1x | 71.4x | 2.6x |
| Sun, 10 Sep 2023 | ₹347.4b | ₹133.8b | ₹4.8b | 30.2x | 72.7x | 2.6x |
| Tue, 08 Aug 2023 | ₹340.8b | ₹120.4b | ₹4.5b | 42.1x | 75.4x | 2.8x |
| Thu, 06 Jul 2023 | ₹335.5b | ₹120.4b | ₹4.5b | 41.5x | 74.4x | 2.8x |
| Sat, 03 Jun 2023 | ₹313.3b | ₹120.8b | ₹4.5b | 40.1x | 69.9x | 2.6x |
| Mon, 01 May 2023 | ₹309.0b | ₹106.7b | ₹16.2b | 29.1x | 19x | 2.9x |
| Wed, 29 Mar 2023 | ₹269.9b | ₹106.6b | ₹16.4b | 23.6x | 16.5x | 2.5x |
| Fri, 24 Feb 2023 | ₹293.2b | ₹106.3b | ₹16.3b | 34.5x | 18x | 2.8x |
| Sun, 22 Jan 2023 | ₹326.2b | ₹99.2b | ₹18.0b | 31.1x | 18.2x | 3.3x |
| Tue, 20 Dec 2022 | ₹347.6b | ₹99.2b | ₹18.0b | 33.8x | 19.4x | 3.5x |
| Thu, 17 Nov 2022 | ₹373.7b | ₹100.5b | ₹17.3b | 35.1x | 21.7x | 3.7x |
| Sat, 15 Oct 2022 | ₹347.7b | ₹95.5b | ₹18.1b | 29.9x | 19.2x | 3.6x |
| Mon, 12 Sep 2022 | ₹398.0b | ₹95.5b | ₹18.1b | 34.1x | 22x | 4.2x |
| Wed, 10 Aug 2022 | ₹415.0b | ₹95.8b | ₹18.3b | 33.8x | 22.7x | 4.3x |
| Fri, 08 Jul 2022 | ₹420.6b | ₹92.1b | ₹17.7b | 31.3x | 23.8x | 4.6x |
| Sun, 05 Jun 2022 | ₹420.9b | ₹92.0b | ₹17.5b | 31.7x | 24x | 4.6x |
Price to Earnings Ratio
24x
Current Industry PE
- Investors are optimistic on the Indian Biotechnology industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 43.0x which is higher than its 3-year average PE of 39.4x.
- The industry is trading close to its 3-year average PS ratio of 3.0x.
Past Earnings Growth
- The earnings for companies in the Biotechnology industry have declined 15% per year over the last three years.
- Meanwhile revenues for these companies have grown 21% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Comparison
How does Indian Biotech compare with similar industries?
| IN Market | 0.50% | |
| Healthcare | -0.11% | |
| Biotech | -1.01% | |
| Biotech | -1.01% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BIOCON Biocon | ₹335.60 | 0.8% +₹3.0b | 8.0% | PE39.6x | |
| PANACEABIO Panacea Biotec | ₹521.20 | 3.4% +₹1.1b | 292.9% | PS5.7x | |
| 524669 Hester Biosciences | ₹1.82k | 2.6% +₹398.1m | 2.2% | PE56.2x | |
| NIRMAN Nirman Agri Genetics | ₹227.35 | 4.1% +₹53.9m | 6.8% | PE6.3x | |
| 524663 Bharat Immunologicals & Biologicals | ₹25.76 | 2.8% +₹30.2m | -12.6% | n/a |